<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="owner">ArrayExpress Uploader</item><item key="ownerprofile_id">arrayexpress_sid</item><item key="species">human</item><item key="factors"><item><item key="GSE6400GSM147368"><item key="Compound">sapphyrin PCI-2050</item><item key="Dose">1.25 uM</item></item></item><item><item key="GSE6400GSM147369"><item key="Compound">sapphyrin PCI-2051</item><item key="Dose">1.25 uM</item></item></item><item><item key="GSE6400GSM147370"><item key="Compound">sapphyrin PCI-2052</item><item key="Dose">1.25 uM</item></item></item><item><item key="GSE6400GSM147520"><item key="Compound">sapphyrin PCI-2053</item><item key="Dose">2.5 uM</item></item></item><item><item key="GSE6400GSM147521"><item key="Compound">sapphyrin PCI-2054</item><item key="Dose">2.5 uM</item></item></item><item><item key="GSE6400GSM147522"><item key="Compound">sapphyrin PCI-2055</item><item key="Dose">2.5 uM</item></item></item><item><item key="GSE6400GSM147099"><item key="Compound">actinomycin D</item><item key="Dose">5 ug/ml</item></item></item><item><item key="GSE6400GSM147099"><item key="Compound">actinomycin D</item><item key="Dose">5 ug/ml</item></item></item><item><item key="GSE6400GSM147099"><item key="Compound">actinomycin D</item><item key="Dose">5 ug/ml</item></item></item><item><item key="GSE6400GSM147365"><item key="Compound">mannitol</item><item key="Dose">5%</item></item></item><item><item key="GSE6400GSM147365"><item key="Compound">mannitol</item><item key="Dose">5%</item></item></item><item><item key="GSE6400GSM147365"><item key="Compound">mannitol</item><item key="Dose">5%</item></item></item></item><item key="id">4837</item><item key="pop_total">0</item><item key="platform">4</item><item key="summary_wrapped">The goal of this project was to characterize changes in gene expression in response to the anti-cancer agent sapphyrin PCI-2050....</item><item key="pubmed_id">17233922</item><item key="geo_gse_id">E-GEOD-6400</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">2</item><item key="sample_count">12</item><item key="tags"><item>cancer</item><item>lung</item><item>lung cancer</item></item><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_id_plat">E-GEOD-6400_A-AFFY-44</item><item key="slug">transcription-profiling-of-human-a549-lung-cance-2</item><item key="geo_gds_id"/><item key="name">Transcription profiling of human A549 lung cancer cells treated with actinomycin D and sapphyrin PCI-2050 a new class of tumor-selective inhibitors of gene expression.</item><item key="created">Sep.21, 2014</item><item key="summary">The goal of this project was to characterize changes in gene expression in response to the anti-cancer agent sapphyrin PCI-2050.  Cultured A549 human lung cancer cells were treated with sapphyrin PCI-2050 or actinomycin D.</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-6400</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-6400/samples/</item></data></biogps>
